China
Nearly half of all Hepatitis B drug sales will happen in China
China’s hepatitis B market will rise from just under £666.6m ($923m) in 2014 to over £1bn ($1.4bn) by 2024, representing a compound annual growth rate (CAGR) of 4.4%, according to GlobalData more »
Feb 29, 2016 11:31 AM News
AstraZeneca looks East with WuXi JV extension
AstraZeneca’s Medimmune biologics business has expanded its existing joint venture WuXi AppTec, the Chinese R&D technology company that it first teamed with in 2012 more »
Dec 17, 2015 12:11 PM News
‘Post-antibiotic era’ may soon be inevitable
The “post-antibiotic world” could soon be a reality due to a gene strain that prevents antibiotics from killing deadly bacteria researchers say more »
Nov 19, 2015 3:40 PM News
UK and China team up on superbug research
The UK and China are to establish a joint fund of £9 million to support research on antimicrobial resistance more »
Oct 26, 2015 11:27 AM News
CPhI China report reveals survey findings
CPhI, a division of UBM EMEA, and UBM Sinexpo have released the findings of their Pharma Insights China 2015 report more »
Aug 13, 2015 11:53 AM News
Achema news: Fette building €12m facility
At Achema, Fette Compacting has announced plans for a new €12m customer facility in Schwarzenbek, Germany. more »
Jun 16, 2015 10:11 AM News
amp biosimilars successfully out-licenses first biosimilar
amp biosimilars has announced its first successful out-licensing of biosimilar ABY-018, a humanised monoclonal antibody. At present, there are four biosimilars in the ampb product pipeline. more »
May 29, 2015 10:30 AM News
Registration fees for drugs and medical devices in China set to soar
China’s drug regulator has raised the fees to register drugs and medical devices in the world’s second-biggest pharmaceutical market, as a lack of resources and expertise hinders its ability to process a rising number of applications. more »
May 29, 2015 12:00 AM News
Aptar's multi-dose approved for China
Aptar Pharma has obtained a State Food and Drug Administration (SFDA) import license approval to deliver its preservative-free multi-dose systems to customers in China. more »
Apr 13, 2015 12:07 PM News
Europe and China – working together in pharma
China’s pharmaceutical output has grown by 719% since 2000. Europe’s next steps in working with the country to shape the global landscape are crucial. Dave Gray looks at the latest efforts to establish ties. more »
Oct 10, 2014 1:26 PM News
GSK in China: time to crack down on Big Pharma?
Online editor Dave Gray looks back on the conclusion of GSK's turbulence in China, and asks what impact this will have on pharma trading around the world. more »
Sep 26, 2014 9:24 AM Editor's Blog
GSK ‘drawing a line’ under China scandal
GlaxoSmithKline has been handed a fine in China of £298.7m for bribing doctors. While the firm tries to repair damage, investigations into corrupt practices overseas continue. more »
Sep 23, 2014 2:20 PM News
DSM to acquire Aland (China) to strengthen vitamin C position
Aland increases DSM's global footprint in vitamins for human nutrition & health, animal nutrition & health and personal care. more »
Jul 31, 2014 12:17 PM
Global hologram trade body targets China growth in new move
Initiative to drive awareness and extend reach. more »
Jul 23, 2014 12:36 PM
Aesica introduces serialisation services at Italian finished dose site
Serialisation services have been introduced for a multinational client’s two anti-allergy product lines at Aeisca’s manufacturing and packaging site in Pianezza, Italy. The packaging lines and associated serialisation services are for one of... more »
Apr 15, 2014 3:52 PM Technology
GEA Diessel Appoints MD to Focus on International Fermentation for Pharma and Biotech
Hans-Peter Casel has taken over as Managing Director of the Liquid Pharma Business for GEA Diessel. The company is the GEA specialist for upstream biotech and pharmaceutical fermentation and part of GEA Pharma Systems, a strategic business unit... more »
Jan 7, 2014 4:47 PM Technology
China’s Strong Economic Growth Generates Success for CPhI
CPhI and UBM live announced that this year’s recent CPhI China 2013, which took place on 25–27 June at the Shanghai New International Expo Centre, was the most successful exhibition to date. more »
Aug 14, 2013 1:31 PM News
CDMO Provides Access to Salbutamol Inhaler Dossier for Chinese Market Approval
Recipharm is working with Vectura Group plc to provide the Chinese regulatory authorities with access to its licence for the regulatory dossier of Asmasal Clickhaler as part of the Chinese market approval process. The regulatory submission will... more »
Jun 21, 2013 3:03 PM Technology
Bright Future Pharmaceutical Purchases Three Carton Packing Lines
Hong Kong pharmaceuticals manufacturer Bright Future Pharmaceutical Ltd has commissioned OYSTAR A+F for three new A+F ModuLine carton packing lines that will package cough syrup sachets. more »
Jun 10, 2013 6:56 PM Technology
First Vision Inspection Machine with Integrated HSA for Chinese Market
Seidenader Maschinenbau has sold its first machine with integrated head space analysis (HSA) to China. HSA is a complementary inspection technology used to check the integrity of pharmaceutical containers. For one Chinese customer, head space... more »
Apr 12, 2013 12:17 PM Technology